-
平臺編號：bio-131061
-
細(xì)胞信息： J.CaM2
-
規(guī)格：1×10?cells/T25培養(yǎng)瓶
-
用途：/
-
服務(wù)費用：
加載中…… - 訂購
-
注意事項：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
人前體T細(xì)胞急性淋巴細(xì)胞白血病細(xì)胞J.CaM2
細(xì)胞名稱：人前體T細(xì)胞急性淋巴細(xì)胞白血病細(xì)胞J.CaM2
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運輸方式：常溫保溫運輸；干冰運輸
安全等級：3
用途限制：僅供科研用途1類
培養(yǎng)體系：DMEM高糖+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡介：人前體T細(xì)胞急性淋巴細(xì)胞白血病細(xì)胞J.CaM2取自14歲男性供體，懸浮培養(yǎng)。
注釋
Transformant:NCIt;C129643;Cesium-137 gamma radiation.
Derived from sampling site:Peripheral blood.
基因突變
Heterozygous for BAX p.Glu41Argfs(c.121delG)and p.Glu41Glyfs(c.121dupG)(from parent cell line).
Heterozygous for FBXW7 p.Arg505Cys(c.1513C>T)(from parent cell line).
Heterozygous for INPP5D p.Gln345Ter(c.1033C>T)and c.1097+1065_1097+1112del47(from parent cell line).
Homozygous for MSH2 p.Arg711Ter(c.2131C>T)(from parent cell line).
Homozygous for MSH6 p.Phe1088Serfs*2(c.3261delC)(from parent cell line).
Heterozygous for SYK p.Met34Hisfs*3(c.98_99insG)(from parent cell line).
Heterozygous for TP53 p.Arg196Ter(c.586C>T)(from parent cell line).
HLA信息:/
STR信息:/
參考文獻(xiàn)
PubMed=3263650;DOI=10.1073/pnas.85.22.8613
Goldsmith M.A.,Dazin P.F.,Weiss A.
At least two non-antigen-binding molecules are required for signal transduction by the T-cell antigen receptor.
Proc.Natl.Acad.Sci.U.S.A.85:8613-8617(1988)
PubMed=9846483;DOI=10.1016/S1074-7613(00)80659-7
Finco T.S.,Kadlecek T.,Zhang W.,Samelson L.E.,Weiss A.
LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.
Immunity 9:617-626(1998)
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6；1x10^6
保存溫度：37℃；-198℃
運輸方式：常溫保溫運輸；干冰運輸
安全等級：3
用途限制：僅供科研用途1類
培養(yǎng)體系：DMEM高糖+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡介：人前體T細(xì)胞急性淋巴細(xì)胞白血病細(xì)胞J.CaM2取自14歲男性供體，懸浮培養(yǎng)。
注釋
Transformant:NCIt;C129643;Cesium-137 gamma radiation.
Derived from sampling site:Peripheral blood.
基因突變
Heterozygous for BAX p.Glu41Argfs(c.121delG)and p.Glu41Glyfs(c.121dupG)(from parent cell line).
Heterozygous for FBXW7 p.Arg505Cys(c.1513C>T)(from parent cell line).
Heterozygous for INPP5D p.Gln345Ter(c.1033C>T)and c.1097+1065_1097+1112del47(from parent cell line).
Homozygous for MSH2 p.Arg711Ter(c.2131C>T)(from parent cell line).
Homozygous for MSH6 p.Phe1088Serfs*2(c.3261delC)(from parent cell line).
Heterozygous for SYK p.Met34Hisfs*3(c.98_99insG)(from parent cell line).
Heterozygous for TP53 p.Arg196Ter(c.586C>T)(from parent cell line).
HLA信息:/
STR信息:/
參考文獻(xiàn)
PubMed=3263650;DOI=10.1073/pnas.85.22.8613
Goldsmith M.A.,Dazin P.F.,Weiss A.
At least two non-antigen-binding molecules are required for signal transduction by the T-cell antigen receptor.
Proc.Natl.Acad.Sci.U.S.A.85:8613-8617(1988)
PubMed=9846483;DOI=10.1016/S1074-7613(00)80659-7
Finco T.S.,Kadlecek T.,Zhang W.,Samelson L.E.,Weiss A.
LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.
Immunity 9:617-626(1998)
